Medicines Co shares rise 12% on US settlement with Teva on Angiomax patents
04 October 2011
Nancy Faigen
Please Login to read the full article.
04 October 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Teva, Mylan settle litigation over generic Nuvigil, allowing US entry by 2016
- Teva in US agrees to 2017 for Vytorin generic, as Merck has other pending cases
- Indian firms lead para IV charge, lock in key first-to-file opportunities
- Generic Provigil hits US market, but Mylan sues over an FDA 180-day exclusivity ruling
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
